Synthetic Biology Market to Surge Ahead at 32.6% CAGR From 2013 – 2019 Supported by Healthcare Applications

Albany, NY, Oct. 21, 2015 (GLOBE NEWSWIRE) — Synthetic biology is on the path to becoming a US$13.4 billion market by 2019, exhibiting a sharp CAGR of 32.6% between 2013 and 2019, estimates Transparency Market Research in its latest report. The report, titled “Synthetic Biology Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast,2013 – 2019“, puts the value of the market at US$1.8 billion in 2012.Synthetic biology is a process that utilizes biology and genetic engineering to produce artificial biological systems and devices. 

Browse the full Synthetic Biology Market (Synthetic DNA, Synthetic Genes, Synthetic Cells, XNA, Chassis Organisms, DNA Synthesis, Oligonucleotide Synthesis) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast,2013 – 2019 report at http://www.transparencymarketresearch.com/synthetic-biology-market.html

The process is proving to be especially pivotal in producing affordable medicines and improved nutritional products. The report zeroes in the following key factors that have shaped the growth curve of the global synthetic biology market: Increased government participation and investments being routed into scientific research as well as active initiatives taken by private players in R&D.

Besides pharmaceutical and nutrition-related applications, synthetic biology has been used for mitigating the damaging effects of marine pollution. The process has been extensively applied for developing engineered microorganisms to limit oil spill damages. Additionally, researchers have successfully used synthetic biology to convert regular plastics into microplastics that can be re-used. With DNA sequencing prices taking a plunge, the synthetic biology market will gain momentum. However, the global synthetic biology market is still impeded by ethical issues relating to synthetic biology products.

Synthetic Biology Market Segmentation by Product, Application, and Technology

The TMR reports offers a highly detailed study of the global synthetic biology market by classifying it on three fronts: Application, products and technologies.

By application, the synthetic biology market is classified according to sectors such as: Healthcare, chemicals, agriculture and others. Of these, the healthcare segment will demonstrate continued growth thanks to factors such synthetic DNA and genes now being commercially available, which in turn supports the development of affordable pharma products.

The segmentation of the synthetic biology market by product has been done as follows: Core products and enabling products. The core products segment is further segregated as: XNA, synthetic DNA, synthetic cells, synthetic genes, and chassis organisms. The enabling products segment, on the other hand, is further divided into products for oligonucleotide synthesis and those for DNA synthesis. According to 2012 estimates, the core products segment enjoyed a larger share of market revenues as compared to enabling products. Based on the type of technology used in synthetic biology processes, the market is segmented as: Biological components and integrated systems, genome engineering, bioinformatics, and DNA sequencing. Technology for synthetic biology genome engineering is observed to be the most widely used as of 2012, because it can efficiently modify specific areas within the DNA to attain better reproducibility. 

Get Sample Research Report: 
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=421

Regional and Competitive Analysis of the Synthetic Biology Market

Findings of the TMR report indicate that Europe will lead the synthetic biology market through the forecast period as a result of active government initiatives and milestones achieved by private players. North America followed Europe in terms of market share as of 2012 through the launch of innovative technologies. Players that yield maximum influence over the synthetic biology market are: DuPont, Inc., Bayer AG, Amyris, Inc., Ginkgo Bioworks, Royal DSM, and Life Technologies Corporation.

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. 

TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

CONTACT: Mr. Nachiket Ghumare
         State Tower,
         90 State Street,
         Suite 700,
         Albany NY - 12207
         United States
         USA - Canada Toll Free: 866-552-3453
         Email: sales@transparencymarketresearch.com
         Website: http://www.transparencymarketresearch.com